Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with D own syndrome

F Meyr, G Escherich, G Mann… - British journal of …, 2013 - Wiley Online Library
Children with D own syndrome (DS) have a greater risk for developing both acute
lymphoblastic leukaemia (ALL) and significant adverse effects of chemotherapy. We …

Future of clinical genomics in pediatric oncology

KA Janeway, AE Place, MW Kieran… - Journal of clinical …, 2013 - ascopubs.org
The somatic genomic alterations in pediatric cancers to some extent overlap with those seen
in adult cancers, but the exact distribution throughout the genome and the types and …

Chromosomal translocations involving the IGH@ locus in B-cell precursor acute lymphoblastic leukemia: 29 new cases and a review of the literature

E Chapiro, I Radford-Weiss, HA Cung, N Dastugue… - Cancer genetics, 2013 - Elsevier
Chromosomal translocations involving the immunoglobulin heavy chain locus (IGH@) are
recurrent but rare in B-cell precursor acute lymphoblastic leukemia (BCP-ALL), and various …

Genetic targets in pediatric acute lymphoblastic leukemia

C Gowda, S Dovat - Impact of Genetic Targets on Cancer Therapy, 2013 - Springer
Acute leukemia represents 31% of all cancers diagnosed in children and 80% of it is of
Lymphoblastic type. Multiple genetic lesions in the hematopoietic progenitor cells prior to or …

Lymphoid malignancies: Another face to the Janus kinases

LM Scott - Blood Reviews, 2013 - Elsevier
Considerable attention has focused on the gain-of-function mutations in the Janus kinase-2
(JAK2) tyrosine kinase that are detectable in most patients with a myeloproliferative …

Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia

I Iacobucci, A Lonetti, C Papayannidis… - Current cancer drug …, 2013 - ingentaconnect.com
Acute leukemias are characterized by recurring chromosomal and genetic abnormalities that
disrupt normal development and drive aberrant cell proliferation and survival. Identification …

The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7-9, 2011

SP Hunger, A Baruchel, A Biondi… - Pediatric blood & …, 2013 - pubmed.ncbi.nlm.nih.gov
The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla,
CA, USA, December 7-9, 2011 The thirteenth international childhood acute lymphoblastic …

No prognostic impact of P2 RY8-CRLF2 fusion in intermediate cytogenetic risk childhood B-cell acute lymphoblastic leukaemia.

J Krawczyk, K Haslam, P Lynam… - British journal of …, 2013 - search.ebscohost.com
The article focuses on a study which aims to determine the impact of cytokine receptor like
factor-2 (CRLF2) gene on patients with B-cell precursor acute lymphoblastic leukaemia …

Anti‐CRLF2 Antibody‐Armored Biodegradable Nanoparticles for Childhood B‐ALL

R Raghunathan, S Mahesula… - Particle & Particle …, 2013 - Wiley Online Library
B‐precursor acute lymphoblastic leukemia (B‐ALL) lymphoblast (blast) internalization of anti‐
cytokine receptor‐like factor 2 (CRLF2) antibody‐armored biodegradable nanoparticles …

Acute lymphoblastic leukemia in adolescents and young adults–from genomics to the clinics

SS Kenderian, MR Litzow - Clinical Oncology in Adolescents and …, 2013 - Taylor & Francis
Acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYA) represents a
unique and challenging disease entity. Despite the recent improvement of survival in this …